Long Non-coding RNA LINC00858 Exerts a Tumor-promoting Role in Colon Cancer Via HNF4α and WNK2 Regulation

Overview

Journal Cell Oncol (Dordr)

Publisher Springer

Date 2019 Dec 30

PMID 31884577

Citations 18

Authors

Ting Xu

Kun Wu

Lei Zhang

Shutao Zheng

Xiaopeng Wang

Hao Zuo

Xu Wu

Guoquan Tao

Baofei Jiang

Li Zhang

Affiliations

Soon will be listed here.

Abstract

Background: Long non-coding RNAs (lncRNAs) are known to be frequently dysregulated in many types of human cancer. As yet, however, their roles in colon carcinogenesis have not been fully elucidated. In the current study, we assessed whether lncRNA LINC00858 may be involved in the progression of colon cancer and, in addition, investigated its downstream targets.

Methods: LINC00858 expression in patient-derived colon cancer tissues and in colon cancer cell lines was determined using RT-qPCR. Also, relationships between LINC00858 expression and various clinicopathological characteristics were analyzed. The subcellular localization of LINC00858 was determined using fluorescence in situ hybridization. Interactions between LINC00858 and its downstream targets were first predicted by bioinformatic analysis and, subsequently, confirmed by RNA pull-down, RNA immunoprecipitation, chromatin immunoprecipitation and dual luciferase reporter assays. After in vitro upregulation of LINC00858 and/or silencing of WNK2 and hepatocyte nuclear factor 4α (HNF4α), the biological behavior of colon cancer cells was assessed using 5-ethynyl-2'-deoxyuridine (EdU) incorporation, Transwell invasion and tube formation assays. In vivo cancer growth was evaluated in nude mice.

Results: We found that LINC00858 was highly expressed in primary colon cancer tissues and colon cancer cell lines, and was mainly located in the nucleus. High LINC00858 expression was found to correlate with a poor differentiation, advanced TNM stages and lymph node metastasis. Exogenous overexpression of LINC00858 promoted cell proliferation, invasion and migration of colon cancer cells, and facilitated angiogenesis and tumor growth. In addition, we found that LINC00858 can bind to and upregulate the nuclear transcription factor HNF4α, leading to WNK2 expression downregulation. This, in turn, resulted in the promotion of colon cancer cell growth.

Conclusions: From our data we conclude that LINC00858 acts as a tumor-promoting lncRNA in colon cancer by upregulating HNF4α and downregulating WNK2. Our results may provide novel targets for the treatment for colon cancer.

Citing Articles

Non-coding RNAs participate in interactions between senescence and gastrointestinal cancers.

Liu Z, Ji F, Piao Y Front Genet. 2025; 15():1461404.

PMID: 39831201 PMC: 11739115. DOI: 10.3389/fgene.2024.1461404.

Long Non-Coding RNAs, Nuclear Receptors and Their Cross-Talks in Cancer-Implications and Perspectives.

Tiwari P, Tripathi L Cancers (Basel). 2024; 16(16).

PMID: 39199690 PMC: 11352509. DOI: 10.3390/cancers16162920.

Retraction: Silencing lncRNA XIST exhibits antiproliferative and proapoptotic effects on gastric cancer cells by up-regulating microRNA-132 and down-regulating PXN.

Li P, Wang L, Li P, Hu F, Cao Y, Tang D Aging (Albany NY). 2024; 16(5):4946-4947.

PMID: 38488766 PMC: 10968674. DOI: 10.18632/aging.205702.

Delineating the role of nuclear receptors in colorectal cancer, a focused review.

Manickasamy M, Jayaprakash S, Girisa S, Kumar A, Lam H, Okina E Discov Oncol. 2024; 15(1):41.

PMID: 38372868 PMC: 10876515. DOI: 10.1007/s12672-023-00808-x.

An update regarding the role of WNK kinases in cancer.

Xiu M, Li L, Li Y, Gao Y Cell Death Dis. 2022; 13(9):795.

PMID: 36123332 PMC: 9485243. DOI: 10.1038/s41419-022-05249-y.

References

Chellappa K, Robertson G, Sladek F . HNF4α: a new biomarker in colon cancer?. Biomark Med. 2012; 6(3):297-300. PMC: 3581081. DOI: 10.2217/bmm.12.23. View

Yan H, Wang Q, Shen Q, Li Z, Tian J, Jiang Q . Identification of potential transcription factors, long noncoding RNAs, and microRNAs associated with hepatocellular carcinoma. J Cancer Res Ther. 2018; 14(Supplement):S622-S627. DOI: 10.4103/0973-1482.204846. View

Jun P, Hong C, Lal A, Wong J, McDermott M, Bollen A . Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific. Neuro Oncol. 2008; 11(4):414-22. PMC: 2743221. DOI: 10.1215/15228517-2008-096. View

Yamada A, Yu P, Lin W, Okugawa Y, Boland C, Goel A . A RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer. Sci Rep. 2018; 8(1):575. PMC: 5766599. DOI: 10.1038/s41598-017-18407-6. View

Lin D, Huang Q, Wu R, Dai S, Huang Z, Ren L . Long non-coding RNA AFAP1-AS1 promoting epithelial-mesenchymal transition of endometriosis is correlated with transcription factor ZEB1. Am J Reprod Immunol. 2018; 81(1):e13074. DOI: 10.1111/aji.13074. View

Hong C, Moorefield K, Jun P, Aldape K, Kharbanda S, Phillips H . Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth. Proc Natl Acad Sci U S A. 2007; 104(26):10974-9. PMC: 1904113. DOI: 10.1073/pnas.0700683104. View

Yao H, Wang J, Zhang X, Wang L, Wang Y, Li X . Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma. Mol Carcinog. 2015; 55(5):458-72. DOI: 10.1002/mc.22294. View

Zhai H, Sui M, Yu X, Qu Z, Hu J, Sun H . Overexpression of Long Non-Coding RNA TUG1 Promotes Colon Cancer Progression. Med Sci Monit. 2016; 22:3281-7. PMC: 5027858. DOI: 10.12659/msm.897072. View

Coleman M, Forman D, Bryant H, Butler J, Rachet B, Maringe C . Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2010; 377(9760):127-38. PMC: 3018568. DOI: 10.1016/S0140-6736(10)62231-3. View

10.

Moniz S, Martinho O, Pinto F, Sousa B, Loureiro C, Oliveira M . Loss of WNK2 expression by promoter gene methylation occurs in adult gliomas and triggers Rac1-mediated tumour cell invasiveness. Hum Mol Genet. 2012; 22(1):84-95. DOI: 10.1093/hmg/dds405. View

11.

Fekry B, Ribas-Latre A, Baumgartner C, Deans J, Kwok C, Patel P . Incompatibility of the circadian protein BMAL1 and HNF4α in hepatocellular carcinoma. Nat Commun. 2018; 9(1):4349. PMC: 6195513. DOI: 10.1038/s41467-018-06648-6. View

12.

Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, Jemal A . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6):394-424. DOI: 10.3322/caac.21492. View

13.

Fu X, Tian Y, Kuang W, Wen S, Guo W . Long non-coding RNA DLX6-AS1 silencing inhibits malignant phenotypes of gastric cancer cells. Exp Ther Med. 2019; 17(6):4715-4722. PMC: 6507526. DOI: 10.3892/etm.2019.7521. View

14.

Chellappa K, Deol P, Evans J, Vuong L, Chen G, Briancon N . Opposing roles of nuclear receptor HNF4α isoforms in colitis and colitis-associated colon cancer. Elife. 2016; 5. PMC: 4907689. DOI: 10.7554/eLife.10903. View

15.

Tam C, Wong J, Tsui S, Zuo T, Chan T, Ng T . LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years. Appl Microbiol Biotechnol. 2019; 103(12):4649-4677. DOI: 10.1007/s00253-019-09837-5. View

16.

Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag C, Morrison D . Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol. 2019; 4(7):511-518. PMC: 7617144. DOI: 10.1016/S2468-1253(19)30147-5. View

17.

Weltmeier F, Borlak J . A high resolution genome-wide scan of HNF4α recognition sites infers a regulatory gene network in colon cancer. PLoS One. 2011; 6(7):e21667. PMC: 3145629. DOI: 10.1371/journal.pone.0021667. View

18.

Pecero M, Salvador-Bofill J, Molina-Pinelo S . Long non-coding RNAs as monitoring tools and therapeutic targets in breast cancer. Cell Oncol (Dordr). 2018; 42(1):1-12. DOI: 10.1007/s13402-018-0412-6. View

19.

Sun Q, Xu W, Ji S, Qin Y, Liu W, Hu Q . Role of hepatocyte nuclear factor 4 alpha in cell proliferation and gemcitabine resistance in pancreatic adenocarcinoma. Cancer Cell Int. 2019; 19:49. PMC: 6398265. DOI: 10.1186/s12935-019-0767-4. View

20.

Moniz S, Verissimo F, Matos P, Brazao R, Silva E, Kotelevets L . Protein kinase WNK2 inhibits cell proliferation by negatively modulating the activation of MEK1/ERK1/2. Oncogene. 2007; 26(41):6071-81. DOI: 10.1038/sj.onc.1210706. View